Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3620754015 | Gastro-resistant oral granules (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3620755019 | Gastro-resistant oral granules | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3620756018 | Enteric-coated oral granules | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Granules for gastro-resistant oral suspension | Is a | False | Gastro-resistant oral granules (dose form) | Inferred relationship | Some | |
| Gastro-resistant and prolonged-release oral granules (dose form) | Is a | True | Gastro-resistant oral granules (dose form) | Inferred relationship | Some | |
| Budesonide 9 mg gastro-resistant oral granules sachet | Has manufactured dose form | True | Gastro-resistant oral granules (dose form) | Inferred relationship | Some | |
| Para-aminosalicylic acid 4 g gastro-resistant oral granules sachet | Has manufactured dose form | True | Gastro-resistant oral granules (dose form) | Inferred relationship | Some | |
| Product containing precisely pancreatic amylase 36 unit/1 milligram and pancreatic lipase 50 unit/1 milligram and pancreatic protease 2 unit/1 milligram gastro-resistant oral granules (clinical drug) | Has manufactured dose form | True | Gastro-resistant oral granules (dose form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR